Targeted Cancer Cell Killing with Antibody Drug Conjugates

A $13B Magic BulletПодробнее

Integrated Strategies to Accelerate Preclinical Development of Antibody-Drug ConjugatesПодробнее

Antibody-drug conjugates(ADCs) current progress and selection of preclinical animal modelsПодробнее

Antibody drug conjugatesADCs current progress and selection of preclinical animal modelsПодробнее

BBC StoryWorks Rewriting Cancer Series | Targeting Cancer with Antibody-drug ConjugatesПодробнее

ADCT Soars 63% TodayПодробнее

Under-the-Radar ADC Innovators to WatchПодробнее

What are cancer targeted therapies? What do precision therapy and personalized medicine mean?Подробнее

Gynecologic Cancer & Antibody Drug Conjugates (ADCs) with Dr. Stephanie BlankПодробнее

221. Antibody Drug Conjugates (ADCs) Dato PotatoПодробнее

Advances in Antibody-Drug Conjugates (ADCs) Development & Preclinical ModelПодробнее

Enfortumab Vedotin (Padcev) for bladder cancerПодробнее

A New Class of Cancer Therapies Targets Solid Tumors with a Dual ActionПодробнее

The Latest in Gynecologic Cancers: The ABCs of ADCs (antibody-drug conjugates)Подробнее

The exciting future of targeted therapies – Exploring new ways to target cancer cellsПодробнее

Latest Breakthroughs in Anti Cancer TreatmentПодробнее

221. Antibody Drug Conjugates (ADCs) Dato PotatoПодробнее

What is targeted therapy? What is immunotherapy? Will they work for my cancer?Подробнее

Understanding Antibody Drug ConjugatesПодробнее